Dermatomyositis

Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis
Spyridon Megremis, Thomas D J Walker, Xiaotong He, William E R Ollier, Hector Chinoy, Lynne Hampson, Ian Hampson, Janine A Lamb

Annals of the Rheumatic Diseases Oct 2020, 79 (10) 1383-1386; DOI: 10.1136/annrheumdis-2020-217522
Response to: ‘On using machine learning algorithms to define clinically meaningful patient subgroups’ by Pinal-Fernandez and Mammen
Olivier Benveniste, Yves Allenbach, Benjamin Granger

Annals of the Rheumatic Diseases Oct 2020, 79 (10) e130; DOI: 10.1136/annrheumdis-2019-216007
Janus kinase (JAK) inhibition with baricitinib in refractory juvenile dermatomyositis
Hanna Kim, Samantha Dill, Michelle O'Brien, Laura Vian, Xiaobai Li, Manuk Manukyan, Minal Jain, Lilian W Adeojo, Jomy George, Maria Perez, Alexei A Grom, Michelle Sutter, Brian M Feldman, Lawrence Yao, Michelle Millwood, April Brundidge, Dominique C Pichard, Edward W Cowen, Yinghui Shi, Shajia Lu, Wanxia Li Tsai, Massimo Gadina, Lisa G Rider, Robert A Colbert

Annals of the Rheumatic Diseases Aug 2020, annrheumdis-2020-218690; DOI: 10.1136/annrheumdis-2020-218690
Machine learning algorithms reveal unique gene expression profiles in muscle biopsies from patients with different types of myositis
Iago Pinal-Fernandez, Maria Casal-Dominguez, Assia Derfoul, Katherine Pak, Frederick W Miller, Jose César Milisenda, Josep Maria Grau-Junyent, Albert Selva-O'Callaghan, Carme Carrion-Ribas, Julie J Paik, Jemima Albayda, Lisa Christopher-Stine, Thomas E Lloyd, Andrea M Corse, Andrew L Mammen

Annals of the Rheumatic Diseases Sep 2020, 79 (9) 1234-1242; DOI: 10.1136/annrheumdis-2019-216599
Response to: ‘Similarities and differences between severe COVID-19 pneumonia and anti-MDA-5 positive dermatomyositis associated rapidly progressive interstitial lung diseases: a challenge for the future’ by Wang et al
Janine A Lamb, Spyridon Megremis, Hector Chinoy

Annals of the Rheumatic Diseases Aug 2020, annrheumdis-2020-218712; DOI: 10.1136/annrheumdis-2020-218712
External validation of EULAR/ACR classification criteria for idiopathic inflammatory myopathies
Queenie Luu, Jessica Day, Alix Hall, Vidya Limaye, Gabor Major

Annals of the Rheumatic Diseases May 2020, annrheumdis-2020-217568; DOI: 10.1136/annrheumdis-2020-217568
Comment on: ‘Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis’ by Sabbagh et al
Zaixing Yang, Yan Liang

Annals of the Rheumatic Diseases Aug 2020, 79 (8) e96; DOI: 10.1136/annrheumdis-2019-215678
Response to: ‘Comment on: ‘Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis’ by Sabbagh S et al’ by Yang et al
Sara Sabbagh, Iago Pinal Fernandez, Frederick W Miller, Lisa G Rider, Andrew Lee Mammen

Annals of the Rheumatic Diseases Aug 2020, 79 (8) e97; DOI: 10.1136/annrheumdis-2019-215693
Response to: ‘Telerheumatology in COVID-19 era: a study from a psoriatic arthritis cohort’ by Costa et al
Latika Gupta, Durga Prasanna Misra, Vishwesh Agarwal, Suma Balan, Vikas Agarwal

Annals of the Rheumatic Diseases Jun 2020, annrheumdis-2020-217953; DOI: 10.1136/annrheumdis-2020-217953
Comment on: ‘Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria’ by Greco et al
Johannes Knitza, Lorenzo Cavagna, Georg Schett, Jörg H W Distler

Annals of the Rheumatic Diseases Jul 2020, 79 (7) e85; DOI: 10.1136/annrheumdis-2019-215484

Main menu

Dermatomyositis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Dermatomyositis

Pages